Coinbase Stock And 2 Founder Led Picks for Long Term Growth

Founder-led companies sit at an interesting crossroad right now. Inflation, central bank moves and energy prices are pulling markets in different directions, while semiconductor demand and commodity cycles add even more cross currents. In this kind of backdrop, many investors prefer leaders who have their own wealth tied to the long term outcome of the business. The Founder-Led Companies screener focuses on exactly that. It filters for stocks where the people in charge have a lasting stake in the value they are building. This article will highlight 3 of the stocks from that screener.

Lightspeed Commerce (TSX:LSPD)

Overview: Lightspeed Commerce provides a cloud-based platform that helps retailers, restaurants and other businesses run everything from the checkout and online ordering to inventory, staff scheduling and customer loyalty, while also handling card payments and financing through Lightspeed Payments and Lightspeed Capital.

Market Cap: CA$1.74b

Investors looking at founder-led businesses may find Lightspeed Commerce interesting because it sits at the center of digital payments, omnichannel retail and restaurant operations, with a single platform that ties together point of sale, e-commerce, inventory and AI driven insights. The stock currently trades below one DCF based fair value estimate and at a lower P/S than many Canadian software peers, which suggests there may be a gap between price and underlying business quality. At the same time, the company is still loss making, faces strong competition from larger rivals and relies on higher risk external funding. As a result, the improving EBITDA trend, AI product initiatives and recent share buybacks are important considerations when assessing whether that risk reward trade off is acceptable.

Lightspeed Commerce sits where founder ownership, AI tools and payments all intersect, yet the market may still be pricing it like a simple point of sale stock. See how the analysis report for Lightspeed Commerce could reshape that view.

Coinbase Global (COIN)

Overview: Coinbase Global runs one of the largest platforms for buying, selling and storing crypto assets, giving consumers, institutions and developers access to trading, custody and a range of onchain tools in the US and internationally.

Market Cap: US$43.10b

Investors watching founder-led platforms may find Coinbase Global interesting because it sits at the center of crypto trading, custody and tokenization while it tries to shift more revenue toward higher margin subscriptions, stablecoins and onchain services. The company is building partnerships with large financial institutions and expanding internationally as regulators in the US, UK and Canada work toward clearer rules. It still faces heavy dependence on spot trading, ongoing losses, fee pressure and high cybersecurity and compliance costs. The Q2 2026 loss and softer trading volumes show how sensitive results can be to crypto cycles, so the real question for you is whether the multi-product “everything exchange” plan can offset these risks over time.

Coinbase Global looks like its “everything exchange” ambitions and push into subscriptions could be masking a very different earnings profile than a pure trading play. Get the full picture in the analyst forecasts for Coinbase Global that many investors may be missing.

Corcept Therapeutics (CORT)

Overview: Corcept Therapeutics is a biopharmaceutical company that develops and commercializes drugs that modulate the hormone cortisol, including Korlym for Cushing’s syndrome and a pipeline of selective cortisol modulators being studied in conditions such as hypercortisolism, metabolic liver disease and Lou Gehrig’s disease.

Market Cap: US$12.79b

Corcept Therapeutics sits at an interesting point for founder-led investors. The company is still heavily tied to Korlym, yet record revenue from Cushing’s syndrome, early sales of Lifyorli in platinum-resistant ovarian cancer and pending FDA review of relacorilant in Cushing’s syndrome could gradually shift it toward a multi-product story. Forecast earnings and revenue growth are ahead of the wider US market and analysts expect strong future returns on equity, but there are important trade offs to weigh, including premium pricing of the stock, legal and regulatory overhang and pressure on drug pricing that could affect margins just as the pipeline scales.

Corcept Therapeutics now looks like a cortisol specialist that is quietly turning into a broader endocrine and oncology story. See how the analyst forecasts for Corcept Therapeutics reveals what that shift could mean next

The three founder-led stocks in this article are just a starting point, since the full Founder-Led Companies screener surfaced 1,453 more companies where leaders have substantial skin in the game and equally compelling narratives. Use Simply Wall St to identify and analyze the specific catalysts, ownership traits and business stories that match your highest conviction ideas so you can focus on the founder-led opportunities that fit your playbook.

Take Control of Your Investment Journey

If Lightspeed Commerce or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Curious To Explore Powerful Alternatives

Fresh opportunities move fast. Some ideas are building quiet breakout momentum while others are still under the radar for now. Scan these curated lists before the crowd and get in early.

• Spot stronger cash generators early by tracking companies in the 7 high quality undervalued stocks that combine solid fundamentals with prices that still look caught on the wrong side of sentiment.
• Ride long term income momentum by reviewing the 6 dividend fortresses where higher yielding stocks with firmer balance sheets could help smooth returns when markets start dropping.
• Position ahead of the next infrastructure wave and see which operators in the 35 power grid technology and infrastructure stocks may benefit if grid upgrades and electrification trends gather pace.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com